Can a common pill stop seizures before they start in brain cancer patients?
NCT ID NCT07130786
Summary
This study is testing whether a medication called levetiracetam (Keppra) can prevent seizures in patients who have brain tumors in a specific, high-risk brain area called the primary motor cortex. The trial will enroll 150 adult patients who have not yet had a seizure. Participants will be randomly assigned to either take the preventive medication or receive the current standard care, which does not include preventive anti-seizure drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.